The predictive value of mid-trimester baPWV combined with sFlt-1/PlGF for the adverse pregnancy outcomes of pregnant women with chronic hypertension: a prospective cohort study
摘要
To explore the predictive value of second-trimester ankle-brachial pulse wave velocity (baPWV) and the soluble fms-like tyrosine kinase−1 to placental growth factor ratio(sFlt−1/PlGF) for adverse pregnancy outcomes among women with chronic hypertension in pregnancy.
MethodsThis prospective cohort study consecutively enrolled pregnant women with chronic hypertension. BaPWV and sFlt-1/PlGF were measured at 22–26 weeks of gestation. The observed pregnancy outcomes included pre-eclampsia (PE), gestational age at delivery, newborn birth weight, preterm birth and small for gestational age (SGA).
ResultsA total of 206 pregnant women with chronic hypertension were enrolled, of whom 108 (52.43%) developed PE. BaPWV did not differ significantly between women who developed PE and those who did not. However, women who subsequently delivered preterm or gave birth to SGA infants had significantly higher baPWV than those without these outcomes (P < 0.001 and P = 0.001). BaPWV was negatively correlated with both gestational age at delivery (r = -0.324, P < 0.001) and neonatal birth weight ( r = །0.26, P = 0.002). Multivariate logistic regression analysis identified elevated baPWV as an independent risk factor for both preterm birth (OR = 2.62, 95% CI: 1.48–4.63, P < 0.001) and SGA (OR = 1.18, 95% CI: 1.08–3.03, P = 0.024). Receiver operating characteristic curve analysis showed that baPWV alone yielded moderate predictive accuracy for preterm birth (AUC = 0.77, 95% CI: 0.69–0.86) and SGA (AUC = 0.72, 95% CI: 0.63–0.81). The combination of baPWV and the sFlt-1/PlGF ratio improved predictive performance, the corresponding AUC values rose to 0.87 (95% CI: 0.79–0.95) for preterm delivery and 0.78 (95% CI: 0.68–0.87) for SGA, respectively.
ConclusionElevated mid-trimester baPWV in pregnant women with chronic hypertension is an independent predictor of preterm birth and SGA. The combination of baPWV and the angiogenic marker sFlt-1/PlGF improves predictive accuracy.